List of Publicly Traded Micro-Cap Medical Device and Equipment Companies
Analyze high-volatility 2026 leaders in medtech, featuring micro-cap innovators in AI diagnostics, robotics, and wearable health technology.
The List of Publicly Traded Micro-Cap Medical Device and Equipment Companies tracks high-growth firms with market capitalizations typically ranging from $50 million to $300 million. As of April 2026, this sector is being propelled by a 25% CAGR in medical wearables and a surge in FDA 510(k) clearances for AI-integrated diagnostics. For a broader view of the industry, investors often reference the List of Medical Device Companies to compare these emerging players against large-cap peers. Successful micro-caps often "graduate" to higher valuation tiers, as seen with former micro-cap names now listed among Mid-Cap Medical Device Companies. Identifying these innovators before major clinical readouts or commercial ramps is essential for capturing outsized returns in the medtech space.
Key Takeaways
Micro-cap medtech is driven by regulatory milestones; over 30 new devices received FDA clearance in 2025, triggering significant price appreciation for firms like KORU Medical.
The wearable medical device market is projected to hit $168B by 2026. Companies focusing on CGM and AFib detection are currently seeing a 25% CAGR.
Surgical and rehabilitative robotics specialists like Myomo are entering pivotal trial phases, attracting investor interest in stroke rehab and vascular automation.
Service-heavy models such as InfuSystem (INFU oncology pumps) provide more stable revenue compared to pure R&D plays, benefiting from chemo delivery trends.
Top List of Publicly Traded Micro-Cap Medical Device and Equipment Companies by Market Cap (2026)
The following rankings feature current micro-cap leaders with significant FDA catalysts and market potential in Q2 2026.
| Rank | Ticker | Company | Focus Area | Market Cap | YTD % | FDA Status | Clinical Catalyst |
|---|---|---|---|---|---|---|---|
| 1 | KRMD | KORU Medical Systems | Infusion Systems | $269M | +50% | Cleared | Commercial Ramp |
| 2 | NYXH | Nyxoah S.A. | Sleep Apnea | $228M | +14% | Gen2 Appr. | Commercial Expansion |
| 3 | PDEX | Pro-Dex, Inc. | Dental/Surgical | $225M | +8% | Active | New Product Launch |
| 4 | CATX | Perspective Therapeutics | Radiopharma/Oncology | $181M | +32% | Pivotal | Trial Readouts |
| 5 | MYO | Myomo, Inc. | Robotics | $173M | +41% | Active | H2 Pivotal Trials |
| 6 | ZTEK | Zentek Ltd. | Wearables/Diagnostics | $153M | +12% | Phase 2 | AI Integration |
| 7 | INFU | InfuSystem (INFU oncology pumps) | Infusion/Oncology | $104M | +5% | Active | Market Expansion |
| 8 | MBOT | Microbot Medical | Vascular Robotics | $86M | +18% | PMA Track | Human Trials |
| 9 | AKYA | Akoya Biosciences | AI Pathology | $65M | -2% | Active | AI Software Phase 2 |
| 10 | CTSO | Cytosorbents (CTSO blood purification) | Critical Care | $52M | +7% | Active | U.S. Commercialization |
List of Publicly Traded Micro-Cap Medical Device and Equipment Companies — Complete Company List
List of Publicly Traded Micro-Cap Medical Device and Equipment Companies Listed on U.S. Exchanges
- List of Medical Device Companies
- Large-Cap Medical Device Companies
- Mid-Cap Medical Device Companies
- Small-Cap Medical Device Companies
Aesthetics
- Cutera, Inc. (CUTR) (Energy-based aesthetic systems)
- Sientra, Inc. (SIEN) (Silicone gel breast implants)
Apparel
- Alpha Pro Tech, Ltd. (APT) (Disposable and limited-use protective apparel products, infection control products, construction weatherization products)
Blood
- Cytosorbents Corporation (CTSO) (Critical care immunotherapy company: blood purification technologies)
Body Worn Devices
- IntriCon Corporation (IIN) (Miniature and micro-miniature body-worn devices: markets include medical, hearing health and professional audio communications)
Cancer
- Icad Inc. (ICAD) (Cancer detection and radiation therapy solutions and services)
- Sensus Healthcare, Inc. (SRTS) (IPO June 3, 2016: medical device company focused on skin cancers as well as other skin conditions)
- TrovaGene, Inc. (TROV) (Platform designed to monitor cancer)
Cells
- Fluidigm Corporation (FLDM) (Single-cell biology market)
Dental
- Biolase, Inc. (BIOL) (Biomedical company: dental lasers and dental imaging equipment)
Diabetes
- Senseonics Holdings, Inc. (SENS) (IPO March 18, 2016: Develops glucose monitoring systems)
- Tandem Diabetes Care, Inc. (TNDM) (Insulin Delivery System)
Diversified
- PAVmed Inc. (PAVM) (IPO April 28, 2016, medical device company: diversified pipeline of innovative products)
Endoscopy
- Motus GI Holdings, Inc. (MOTS) (IPO February 14, 2018; medical device company)
Eyes
- EyePoint Pharmaceuticals, Inc. (EYPT) (Drug delivery products to treat chronic eye disease)
- Iridex Corporation (IRIX) (Laser consoles, laser probes, delivery devices, consumable instrumentation)
- Presbia Plc. (LENS) (IPO in January 2015, Ireland: Optical lens implant)
- Second Sight Medical Products, Inc. (EYES) (Implantable visual prosthetics)
Furniture
- Kewaunee Scientific Corporation (KEQU) (Laboratory, healthcare and technical furniture products)
Hair Restoration
- Restoration Robotics, Inc. (HAIR) (IPO October 12, 2017: ARTAS Robotic Hair Transplant System)
Heart
- Neovasc Inc. (NVCN) (Canada: cardiovascular products)
Home Medical Devices
- Tactile Systems Technology, Inc. (TCMD) (IPO July 28, 2016: at-home medical devices)
Knee Implants
- ConforMIS, Inc. (CFMS) (IPO in July 2015: Customized knee implants)
Laboratory Equipment
- Harvard Bioscience, Inc. (HBIO) (Apparatus and scientific instruments including laboratory fluidics, lab equipment and supplies, molecular analysis products, physiology products)
Medical Imaging
- Digirad Corporation (DRAD) (Nuclear cardiology and ultrasound imaging, cardiac event monitoring services, medical diagnostic imaging systems)
- Fonar Corporation (FONR) (MRI scanners)
- iRadimed Corporation (IRMD) (MRI compatible products, non-magnetic intravenous infusion pump systems)
Medical Robotics
- Corindus Vascular Robotics, Inc. (CVRS) (Robotic assisted percutaneous coronary intervention technologies)
- Microbot Medical Inc. (MBOT) (Micro-robotic medical technologies)
- ReWalk Robotics Ltd. (RWLK) (Israel: exoskeletons that allow wheelchair-bound individuals to walk again)
- TransEnterix, Inc. (TRXC) (Robotics and flexible instruments)
Medical Supplies
- InfuSystems Holdings, Inc. (INFU) (Ambulatory infusion pumps and associated disposable supply kits)
Obesity
- Apollo Endosurgery, Inc. (APEN) (Medical devices used in the treatment of obesity)
Pediatric
- OrthoPediatrics Corp. (KIDS) (IPO October 12, 2017; pediatric orthopedic medic devices)
Photonics
- Invuity, Inc. (IVTY) (IPO in June 2015: Advanced photonics medical technologies)
Prenatal and Newborn
- Utah Medical Products, Inc. (UTMD) (Labor and delivery, obstetrics)
Spine
- InVivo Therapeutics Holdings Corp. (NVIV) (Technologies and treatments for spinal cord injuries)
- Nuvectra Corporation (NVTR) (Neurostimulation medical device company)
- RTI Surgical, Inc. (RTIX) (Orthopedic and other surgical implants)
- SeaSpine (SPNE) (Medical technology company: orthobiologics and spinal fusion hardware)
Surgical Devices and Products
- Bovie Medical Corporation (BVX) (Electrosurgical products and technologies; medical products used in doctor’s offices, surgery centers and hospitals)
- MISONIX, Inc. (MSON) (Ultrasonic surgical devices: applications include advanced wound care, neurosurgical, spinal and general surgery procedures)
Urological Diseases
- EDAP TMS S.A. (EDAP) (France: Minimally invasive medical devices used primarily for urological diseases)
Vascular
- Avinger, Inc. (AVGR) (Image-guided, catheter-based systems used to treat patients with peripheral arterial disease)
Weight Loss
- Obalon Therapeutics, Inc. (OBLN) (IPO October 6, 2016: medical devices designed to promote weight loss)
Women’s Health
- Viveve Medical, Inc. (VIVE) (IPO June 14, 2016: women’s health company)
Risks & Considerations
High R&D Burn Rates
Most micro-cap medtech firms prioritize development over profitability. Investors should monitor cash runways closely, as secondary offerings can lead to significant shareholder dilution during lengthy clinical trials.
Regulatory Dependency
Stock valuations are often tied to single FDA milestones. A rejection or a "Request for Additional Information" (AI) can lead to immediate capital loss and delayed commercialization timelines.
Intense Market Competition
Micro-caps often compete against diversified giants. Even with superior tech, these smaller firms may struggle with hospital distribution networks and reimbursement negotiations without a major partner.
Liquidity & Volatility
Low daily trading volumes can cause extreme price swings. Exiting a position in a micro-cap device stock during a negative news cycle can be difficult without significantly impacting the market price.